10:06 AM EST, 03/05/2024 (MT Newswires) -- Analog Devices ( ADI ) said Tuesday that it has commercially launched its Sensinel cardiopulmonary management system after securing the US Food and Drug Administration's clearance for the wearable device.
The company said Sensinel captures cardiopulmonary measurements for management of chronic disease such as heart failure.
Price: 194.19, Change: -0.47, Percent Change: -0.24